Abstract
In May Fisons introduced a new formulation of sodium cromoglycate eyedrops (Opticrom) for use in allergic eye disease including hay fever. Until now the drops have been aqueous, and for use four times daily. The new viscous formulation, based on hypromellose (normally used four times daily as a tear substitute), is intended for twice daily use under the same name. The aqueous drops have been renamed ‘Opticrom Aqueou’; patients prescribed ‘Opticrom’ will get the new product unless the aqueous preparation is specified. Opticrom Aqueous has been difficult to obtain in some areas.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
